DISHMAN

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the final Dividend, if declared by the members at the Annual General Meeting to be held on September 29, 2015 will be paid on or after September 30, 2015.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the consolidated financial results for the period ended 31-Mar-2015.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 12, 2015 to September 29, 2015 (both days inclusive) for the purpose of Final dividend & Annual General Meeting of the Company scheduled to be held on September 29, 2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on August 22, 2015 has recommended the Final dividend @100% (i.e. Rs. 2.00 per equity share of Rs. 2.00 each) on the paid-up equity share capital of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from August 23, 2015 to September 02, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome of Extra Ordinary General Meeting and Details of voting as per Clause 35A of the Listing Agreement along with copy of Scrutinizer's Report.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from August 15, 2015 to August 24, 2015 (both day inclusive). During this period, Directors, Designated Persons and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the e-voting facility for the Extra Ordinary General Meeting to be held on August 14, 2015, is availabe from August 11, 2015 to August 13, 2015.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange copy of Notice of Extra Ordinary General Meeting to be held on August 14, 2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that at the Board Meeting held on July 17, 2015, the board has deffered the agenda pertaining to Approval of Audited Annual Accounts, consequently, the decision of declaration of Dividend has also been deffered.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome of the Board Meeting held on July 17, 2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from July 11, 2015 to July 19, 2015 (both day inclusive). During this period, Directors, Designated Persons and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board has deferred the Agenda relating to approval of the Audited financial statements for the year ended March 31, 2015 in view of disagreement with the statutory auditors with regard to reporting in the consolidated financial statements regarding accounting of employee pension benefits by the Swiss subsidiary CARBOGEN AMCIS, which is covering this liability by participating in an employee retirement benefit plan of a large and well respected insurance company. As per Swiss GAAP, the said subsidiary has no liabil

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that due to unavoidable circumstances, the Meeting of Board of Directors of Company which was scheduled to be held on May 25, 2015 is hereby postponed to May 28, 2015. In view of this it has been decided to extend the Window Closure Period till May 30, 2015.(Revised)

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015 and SEBI Circular bearing No.CIR/ISD/01/2015 dated 11th May, 2015, the Company has formulated a Code of Conduct for Prevention of Insider Trading. The same has also been disseminated to the employees of the Company for their information and compliance. Enclosed is Code of Practices and Procedure for fair disclosure adopted by the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from May 5, 2015 to May 27, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Janmejay R. Vyas has informed the Exchange that has submitted to the Exchange vide letter dated April 08, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of Directors vide circular resolution dated April 2, 2015, have approved the appointment of Mr. Rajendra S. Shah as an Additional Director of the Company, Mr. Rajendra S. Shah shall hold office as an Additional Director w.e.f. April 2, 2015 till the ensuing Annual General Meeting of the Company. The Board has considered him as an Independent Director in terms of the provisions of the Companies Act, 2013 and Listing Agreement.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Dec-2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from February 2, 2015 to February 14, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Ratings assigned by India Ratings and Research Pvt. Ltd.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of Minutes of Proceedings of Declaration of Result of Postal Ballot of the Company held on 13th January, 2015.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange vide letter dated January 19, 2015 regarding news clarification.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Result of Postal Ballot & Voting Results under Clause 35A.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding appointment of Mr. S. K. Das as Independent Director on the Board of the Company and Resignation of Mr. Y.B.Desai as an Independent Director of the Company.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of Notice of Postal Ballot pursuant to Section 110 of the Companies Act, 2013.

The Exchange had sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to a news item captioned "Dishman Pharma in talks with investor to sell land in Gujarat". The company has clarified that "Dishman Pharmaceuticals and Chemicals Limited (DPCL) had acquired on a long term lease basis Land located at the Pharma and Finechem SEZ being developed by Dishman Infrastructure Limited (DIL), a company promoted by the promoters of DPCL. However, owing to withdrawal of the benefits granted earlier to SEZ developers/units located there in by the Government, the said company

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "Dishman Pharma in talks with investor to sell land in Gujarat". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Wheth

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated November 19, 2014 a copy of disclosure in terms of Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

HDFC Standard Life Insurance Co. Ltd has submitted to the Exchange vide letter dated November 18, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that for the purpose of Postal Ballot, the Company has fixed cut-off date November 14, 2014 for the purpose of voting on Postal Ballot for both electronically and voting through Ballot paper. The Company will provide the e-voting facility of CDSL to its members for the businesses to be transacted through Postal Ballot.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that pursuant to Section 110 of the Companies Act, 2013, read with Rule 22 of the Companies (Management and Administration) Rules, 2014, Company proposes to conduct Postal Ballot for obtaining the approval of Members of the Company by Special Resolution.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Sep-2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Date of the Board Meeting has been postponed, instead of November 12, 2014 to November 13, 2014 inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended September 30, 2014. In view of the same, the trading window for the Designated Employees of the Company shall remain close from November 01, 2014 to November 14, 2014 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of th

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board Meeting of the Company is scheduled to be held on November 12, 2014 inter alia, to consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended 30th September, 2014. In view of the same, the trading window for the Designated Employees of the Company shall remain closed from 1st November, 2014 to 13th November, 2014 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Comp

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated October 17, 2014 disclosure in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Revision in Ratings for Outstanding Non-Convertible Debenture issue (listed debt instruments) and Credit Rating for Banking Facilities of Company by CARE Rating Agency.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated October 2, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of minutes of Annual General Meeting of the Company held on September 04, 2014.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of Scrutinizer's Report on the results of the voting through electronic system and physical mode in respect of all resolutions passed at Annual General Meeting of the Company held on September 04, 2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the details of voting at the Annual General Meeting of the Company as per clause 35A of the Listing agreement.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome Annual General Meeting of the Company held on September 04, 2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding a Outcome of Board Meeting of the Company held on August 13, 2014.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Jun-2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that For the purpose of 31st Annual General Meeting, the Company will provide the e-voting facility to its members in respect of the businesses to be transacted at 31st Annual General Meeting schedule to be held on 4th September, 2014. Therefore, the Company has fixed 25th July, 2014 as cut off date for the purpose of determining the members entitled to vote electronically.

Janmejay R Vyas has submitted to the Exchange vide letter dated July 19, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated June 12, 2014 a copy of Disclosure in terms of Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.